Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China

European Journal of Preventive Cardiology

Volumn 16, Issue 1, 2009, Pages 96-101

  Qin, Xueying ^a   Jackson, Rod ^b   Marshall, Roger ^b   Lee, Liming ^a   Cao, Weihua ^a   Zhan, Siyan ^a   hu, Yonghua ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

cardiovascular diseases; hypertension; population wide strategy; targeted strategy

Indexed keywords

ANTIHYPERTENSIVE AGENT; SODIUM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MODEL; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; SEX RATIO; SODIUM RESTRICTION; STROKE; TREATMENT OUTCOME; URBAN AREA; BIOLOGICAL MODEL; MIDDLE AGED; RISK ASSESSMENT; URBAN POPULATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CHINA; COHORT STUDIES; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; RISK ASSESSMENT; URBAN POPULATION;

EID: 65649142186     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32831fd6de     Document Type: Article

References (29)

1. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32–38.
2. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, et al Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332: 659–662.
3. Capewell S, Belgin J, Zhao D, Laatikainen T, Vartiainen E, Macara A, et al Rapid response to: Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332: 659–662. http://www.bmj.com/cgi/eletters/332/7542/659#130902.
4. Whincup PH, Emberson J, Morris R. Rapid response to: Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332: 659–662. http://www.bmj.com/cgi/eletters/332/7542/659#130931.
5. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124–1134.
6. Jackson R, Lynch J, Harper S. Preventing coronary heart disease. BMJ 2006; 332: 617–618.
7. Hu YH, Lee LM, Wei HC, Zhan SY. Community-based comprehensive prevention and control of hypertension in China (CCPACH study)-prevalence and epidemiological characteristics in urban and rural areas. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 177–180.
8. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, et al Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006; 114: 2217–2225.
9. Liu L, Gong L, Wang W. Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial. Chin J Cardiol 2005; 33: 613–617.
10. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 1998.
11. Assessment and Management of Cardiovascular Risk. New Zealand Guidelines Group. Dec. 2003 http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm?guidelineID=35.
12. Chinese Hypertension Guideline Committee. Chinese hypertension guideline. Chin J Hypertens 2005; 13 (Suppl):3–41.
13. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 2007; 25: 2011–2018.
14. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure J Hypertens 2000; 18 (Suppl 2):S91–S92.
15. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885.
16. Lawes CM, Bennett DA, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2002; 2: 355–368.
17. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 1024.
18. Sabate E. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003.
19. Liu L. Cardiovascular diseases in China. Biochem Cell Biol 2007; 85: 157–163.
20. National Center for Cardiovascular Disease. 2005 report on cardiovascular diseases in China. Beijing: Encyclopedia of China Publishing House; 2006.
21. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004; 25: 484–491.
22. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675–687.
23. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva, World Health Organization, 2007 http://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf.
24. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.
25. Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981–2000: comparing contributions from primary prevention and secondary prevention. BMJ 2005; 331: 614.
26. Wu X, Duan X, Hao D, Tao S, Fang W. Prevalence and Development Trends of Hypertension in China. Chin J Hypertens 1995; 3: 7–13.
27. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361: 717–725.
28. Cardiovascular diseases. Feb. 2007. World Health Organization http://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf.
29. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, et al Proportion of different subtypes of stroke in China. Stroke 2003; 34: 2091–2096.